Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 19, 2021 - Issue 1
Submit an article Journal homepage
1,170
Views
2
CrossRef citations to date
0
Altmetric
Editorial

‘Will the king ever be dethroned?’ The relationship and the future of oral anticoagulation therapy versus LAA closure devices

Alexandru Burlacua Department of Interventional Cardiology, Cardiovascular Diseases Institute, Iasi, Romania;b 'Grigore T. Popa’ University of Medicine, Iasi, RomaniaORCID Iconhttps://orcid.org/0000-0002-3424-1588View further author information
ORCID Icon,
Simonetta Genovesic Department of Medicine and Surgery, University of Milan Bicocca and Nephrology Unit, Monza, ItalyORCID Iconhttps://orcid.org/0000-0002-4699-4149View further author information
ORCID Icon,
Bogdan Artenea Department of Interventional Cardiology, Cardiovascular Diseases Institute, Iasi, RomaniaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3201-1105View further author information
ORCID Icon &
Adrian Covicb 'Grigore T. Popa’ University of Medicine, Iasi, Romania;d Nephrology Clinic, Dialysis, and Renal Transplant Center, ‘C.I. Parhon’ University Hospital, Iasi, RomaniaORCID Iconhttps://orcid.org/0000-0002-9985-2486View further author information
ORCID Icon
Pages 1-4 | Received 04 Sep 2020, Accepted 10 Nov 2020, Published online: 25 Nov 2020

References

  • Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492–501.
  • Steinberg BA, Greiner MA, Hammill BG, et al. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation. Cardiovasc Ther. 2015;33(4):177–183.
  • Rein NV, Heide-Jørgensen U, Lijfering WM, et al. Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy. Circulation. 2019;139(6):775–786.
  • Johnson WD, Ganjoo AK, Stone CD, et al., The left atrial appendage: our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg. 2000;17(6):718–722.
  • Kleinecke C, Gloekler S, Meier B. Utilization of percutaneous left atrial appendage closure in patients with atrial fibrillation: an update on patient outcomes. Expert Rev Cardiovasc Ther. 2020;18(8):517-530.
  • Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.
  • Hindricks G, Potpara, T, Dagres, N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J. 2020 Aug 29:ehaa612, 00: 1-125.
  • Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. Jama. 2014;312(19):1988–1998.
  • Holmes DR Jr., Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.
  • Osmancik P, Herman D, Neuzil P, et al., Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–3135.
  • Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012;98(15):1120–1126.
  • Cresti A, García-Fernández MA, Sievert H, et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroIntervention. 2019;15(3):e225–e230.
  • Meier B, Blaauw Y, Khattab AA, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention. 2015;10(9):1109–1125.
  • Boersma LV, Ince H, Kische S, et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017;14(9):1302–1308.
  • Landmesser U, Tondo C, Camm J, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention. 2018;14(5):e590–e597.
  • Davis C 3rd, Rembert J, Greenfield J Jr. Compliance of left atrium with and without left atrium appendage. Am J Physiol Heart Circ Physiol. 1990;259(4):H1006–H1008.
  • Behnes M, Sartorius B, Wenke A, et al. Percutaneous closure of left atrial appendage affects mid-term release of MR-proANP. Sci Rep. 2017;7(1):9028.
  • Granier M, Laugaudin G, Massin F, et al. Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure. J Invasive Cardiol. 2018;30(7):245–250.
  • Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–542.
  • Genovesi S, Porcu L, Slaviero G, et al. Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis. J Nephrol. 2020, Epub ahead of print:1–11.
  • Bai R, Horton RP, Di Biase L, et al. Intraprocedural and long‐term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience. J Cardiovasc Electrophysiol. 2012;23(5):455–461.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.